U.S. Construction Stock News

Sionna Therapeutics (SION) is back in focus after reporting Phase 2a data showing that lead cystic fibrosis candidate SION-719 missed its key efficacy endpoint as an add-on to Trikafta, prompting the company to halt development. See our latest analysis for Sionna Therapeutics. The failed Phase 2a readout for SION-719 has been followed by sharp share price volatility, with Sionna Therapeutics’ stock down 86.8% on a 7 day share price return and 84.1% on a year to date share price return, while...

NNN REIT has delivered a 40.2% return over the past three years, and the current share price of US$45.81 still screens as cheap relative to an intrinsic value estimate based on a Discounted Cash Flow (DCF) model and traditional multiples. The 40.2% gain over three years suggests investors have already seen solid value creation, yet current indicators still point to room between price and estimated worth. Future cash flows from long term, triple net leases can support this valuation view...

PENN Entertainment has put long term shareholders through a rough ride, with the share price down about 71% over the past 5 years, yet the stock now screens as cheap on several valuation checks. Recent news around stronger physical casino performance and increased iGaming investment has refocused attention on whether the current price reflects the company’s mix of mature retail assets and a more competitive online business. The roughly 71% share price decline over 5 years leaves PENN...

In August 2026, Clarivate Plc expanded agentic AI capabilities across its Cortellis life sciences portfolio, embedding AI into drug discovery, safety assessment and portfolio decision workflows to reduce manual effort and support faster, evidence-based decisions. By integrating multi-agent AI directly into Cortellis tools like Drug Discovery Intelligence, OFF-X and Competitive Intelligence, Clarivate is turning previously time-intensive R&D and market analysis tasks into higher-value,...

Lincoln Electric Holdings (LECO) has drawn fresh attention after reporting second quarter and first half 2026 results that showed higher year-on-year sales and net income, alongside continued progress on its multi year share repurchase program. See our latest analysis for Lincoln Electric Holdings. Lincoln Electric Holdings’ recent earnings update and ongoing buybacks appear to have supported sentiment, with a 14.24% 1 month share price return and a 17.73% year to date share price return. The...

Service Corporation International has delivered a 42.8% share price gain over the past three years, yet its valuation checks look mixed, with an intrinsic value estimate from a Discounted Cash Flow (DCF) model indicating meaningful upside relative to the current US$84.40 share price. Over the last three years, Service Corporation International shares are up 42.8%, which puts recent returns in focus when judging whether the stock still offers value. Future cash flow expectations and the...

Eton Pharmaceuticals (NasdaqGM: ETON) licensed U.S. rights to ASN-001, a potential first FDA-approved topical therapy for infantile hemangiomas, from Auson Pharmaceuticals. The agreement centers on ASN-001, which targets an unmet need in pediatric dermatology where no FDA-approved topical treatments for infantile hemangiomas are currently available. Eton plans to leverage its existing pediatric dermatology infrastructure, including HEMANGEOL, to support development and potential...

Smurfit Westrock previously announced it would raise containerboard prices by US$100 per tonne from 1 September 2026, following several earlier hikes across major producers and drawing criticism from the AICC, which argued these increases were not justified by raw material costs or broader economic conditions. This push to lift containerboard pricing highlights the company’s ongoing effort to enhance revenue quality and profitability against a backdrop of questioned industry-wide pricing...

Activist investor Anson Funds is publicly urging Lionsgate Studios (NYSE:LION) to reshape its business for the AI era or consider a sale. The firm is questioning how Lionsgate Studios communicates the value of its film library and broader assets to investors as generative AI changes the media sector. The campaign could influence Lionsgate Studios' future direction, including possible M&A discussions and new approaches to monetizing content with AI tools. Lionsgate Studios is not the only...

DiamondRock Hospitality (DRH) has investors’ attention after its second quarter 2026 update, which combined stronger earnings, a higher dividend and an active capital return program. The company also flagged interest in acquisition opportunities. See our latest analysis for DiamondRock Hospitality. DiamondRock Hospitality’s share price has climbed 34.1% year to date and 16.5% over the past 90 days, while its 1 year total shareholder return of 57.9% points to strengthening momentum as recent...

International Bancshares Corporation has reported past second-quarter 2026 results, with net interest income rising to US$171.11 million while quarterly net income eased to US$95.81 million and earnings per share from continuing operations dipped to US$1.54. Despite the softer quarter, the first half of 2026 showed relatively steady profitability and the board approved a US$0.73 per-share cash dividend, underscoring the bank’s continued capital return to shareholders. Next, we examine how...

With the Fed weighing another possible rate hike in September, inflation still above target and war with Iran keeping energy markets on edge, short term interest rates sit at the center of the story again. This mix can rattle growth stocks; yet it can also open space for certain financials to use higher rates to their advantage. This article walks through three U.S. financial stocks that may benefit from higher short term interest rates and are closely tied to this news backdrop. The three...

Etsy (NYSE:ETSY) is facing rising seller frustration over new AI content policies that govern how AI generated designs and listings are treated on the platform. Long term sellers report concerns that AI generated products are crowding search results and blurring quality standards, raising questions about Etsy's brand identity. Rival marketplaces are starting to ban AI generated items entirely, positioning themselves as alternatives for creators who want human made goods. The widening policy...

Four Corners Property Trust recently acquired five Novant Health Urgent Care properties in South Carolina for US$11.7 million at a 6.9% cap rate, along with a Sun Auto Tire & Service property in North Carolina for US$2.5 million under a long-term triple net lease. These additions deepen FCPT’s exposure to essential, service-oriented real estate in strong retail corridors, aligning with its push to broaden beyond restaurant-heavy rents and diversify tenant risk. Next, we’ll examine how adding...

eToro Group stock has fallen sharply over the past year, yet the current market price still screens as cheap against both an intrinsic value estimate from the Excess Returns model and traditional valuation multiples. That combination puts the recent share price weakness and the current valuation message at odds for investors trying to assess what the stock is really pricing in. Over the past 12 months, eToro Group shares are down about 40.7%, which means recent buyers have faced a steep...

Jade Biosciences (JBIO) released its second quarter 2026 results on 10 August, reporting a net loss of $55.77 million and basic loss per share from continuing operations of $0.76. Investors now have fresh data to assess the stock. See our latest analysis for Jade Biosciences. Jade Biosciences’ latest results land after a year of strong momentum, with a year to date share price return of 63.91% and a 1 year total shareholder return of 216.64%, even though the 90 day share price return declined...

Applied Aerospace & Defense (AADX) shares were in focus after the company issued full year 2026 revenue guidance of US$670 million to US$690 million, alongside record second quarter results and a growing contract backlog. See our latest analysis for Applied Aerospace & Defense. Applied Aerospace & Defense’s recent guidance and record quarter came alongside a share price of US$19.11, with the stock falling 7.19% on a 1 day share price return and 9.94% on a 7 day share price return, while the...

In recent days, Prudential Financial, Inc. declared a past quarterly dividend of US$1.40 per common share, payable on September 10, 2026 to shareholders of record on August 25, 2026, while also issuing multiple fixed-rate senior unsecured notes maturing between 2031 and 2036 and reporting higher Q2 2026 net income and diluted EPS versus a year earlier. Together with progress on its share repurchase program and comments about disciplined, outcomes-focused acquisitions, these actions highlight...

LENZ Therapeutics slipped 3.3% to about US$5 today, yet the earnings story is less about the red on your screen and more about how much cash and conviction this eye care specialist still has behind VIZZ. The headline is simple. Q2 2026 brought modest revenue of US$5.5m and a sizeable net loss of US$31.9m, but LENZ closed the quarter with roughly US$220m in cash and securities. The stock came into this print already under pressure over 90 days, so today’s move looks like a market leaning...

Why Coca-Cola Consolidated’s Latest Earnings Matter For Stock Watchers Coca-Cola Consolidated (COKE) recently reported second quarter 2026 results that showed higher sales but lower net income compared with a year earlier. That mix of revenue growth and earnings pressure gives investors new information to weigh. See our latest analysis for Coca-Cola Consolidated. The mixed second quarter earnings have come alongside a strong share price run, with Coca-Cola Consolidated’s stock delivering a...

Replimune Group stock has delivered a very strong 199.4% return over the past year, yet the broader valuation checks still flag the shares as leaning expensive rather than a clear bargain. Over the last 12 months, Replimune Group has returned 199.4%, which puts extra focus on whether the recent share price strength is already baking in optimistic expectations. The FDA advisory panel endorsement of RP1 for advanced melanoma can support higher growth expectations for the business, while...

Vor Biopharma has seen its share price fall about 92.0% over the past five years, even as current valuation checks on the stock now point to a mixed picture rather than a clear bargain or clear overpricing. After a sharp long term decline combined with a strong rebound this year, investors are weighing whether the recent enthusiasm is justified by what the valuation signals suggest about the current price. Over the past five years the stock has declined about 92.0%, which puts a spotlight on...

Kopin stock cooled off after the earnings release, slipping 3.5% to US$5.02, even though the quarter delivered what many investors have been waiting for. The semiconductor display specialist posted Q2 revenue of US$12.7m and swung to a small profit of roughly US$0.9m, helped by grants and collaboration income tied to its defense and optics work. The real story is the margin and profit squeeze behind that headline profit, and whether a triple digit P/E that leans on one off gains still makes...

Urban Edge Properties (UE) drew fresh attention after reporting its second quarter and first half 2026 results, raising full year earnings guidance and affirming its regular dividend, giving investors new numbers to assess. See our latest analysis for Urban Edge Properties. Against this backdrop, Urban Edge Properties' share price is at US$21.81, with a 1-day share price return of 0.83% and year to date share price return of 14.19%. The 1-year total shareholder return of 15.38% and 3-year...